Inovio Pharmaceuticals, Inc.
INONasdaqCIK 1055726HealthcareFiscal year ends Dec 31
Reports and events: 246 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-415555 |
| 2026-08-1220:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-26-000024 |
| 2026-08-1220:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001055726-26-000023 |
| 2026-07-3111:23 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326785 |
| 2026-07-2920:03 ET | 8-K | 2.02 Results of operations | 0001193125-26-323628 |
| 2026-05-2020:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-232524 |
| 2026-05-1320:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-26-000019 |
| 2026-05-1320:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001055726-26-000018 |
| 2026-04-0720:11 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001055726-26-000011 |
| 2026-04-0611:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-142885 |
| 2026-04-0210:15 ET | 8-K | 8.01 Other events | 0001193125-26-138870 |
| 2026-03-1220:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-26-000009 |
| 2026-03-1220:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001055726-26-000008 |
| 2026-01-2721:12 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-024431 |
| 2025-12-2913:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-332322 |
| 2025-11-1211:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-275721 |
| 2025-11-1021:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000064 |
| 2025-11-1021:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001055726-25-000063 |
| 2025-08-1220:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000056 |
| 2025-08-1220:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001055726-25-000055 |
| 2025-07-0711:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-155830 |
| 2025-05-2221:15 ET | 8-K | 5.07 Shareholder vote results | 0001055726-25-000045 |
| 2025-05-1320:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000027 |
| 2025-05-1320:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001055726-25-000026 |
| 2025-04-0720:08 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0001055726-25-000018 |
| 2025-03-1820:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000013 |
| 2025-03-1820:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001055726-25-000012 |
| 2024-12-1613:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-279061 |
| 2024-11-1421:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-24-000053 |
| 2024-11-1421:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001055726-24-000052 |
| 2024-08-1310:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-199331 |
| 2024-08-0821:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-197065 |
| 2024-08-0820:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001055726-24-000046 |
| 2024-05-2820:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-148076 |
| 2024-05-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-137228 |
| 2024-05-1320:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001055726-24-000020 |
| 2024-04-1720:04 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-099067 |
| 2024-04-1120:10 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001055726-24-000014 |
| 2024-03-0621:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001055726-24-000011 |
| 2024-01-2521:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-015380 |
| 2024-01-1222:27 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-007674 |
| 2023-11-2821:05 ET | DEF 14A | Proxy statementPeriod 2024-01-12 | 0001193125-23-284277 |
| 2023-11-0921:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-274515 |
| 2023-11-0921:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001055726-23-000055 |
| 2023-11-0220:01 ET | 8-K | 3.01 Delisting notice | 0001193125-23-269347 |
| 2023-10-1020:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-253450 |
| 2023-08-0920:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-207397 |
| 2023-08-0920:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001055726-23-000051 |
| 2023-08-0101:43 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-23-199683 |
| 2023-06-2320:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-173847 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.